Utilizing Response and Biology Based Risk Factors to Guide Therapy in Patients with Non-High Risk Neuroblastoma
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Neuroblastoma
-
Age: Between 6 years - 18 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
1) Patients must have newly diagnosed MYCN non-amplified neuroblastoma (ICD-O morphology 9500/3) or MYCN non-amplified ganglioneuroblastoma verified by histology. 2) Patients who have no life threatening symptoms or no impending neurologic or other organ function compromise.
You may not be eligible for this study if the following are true:
-
1) Patients with MYCN amplified tumors are not eligible.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
